Lung Cancer Research and Clinical Trials
Tremendous Hope on the Horizon
In recent years, remarkable progress has been made in the battle against all types of cancer. Researchers believe they are getting closer to techniques for earlier diagnosis, new therapies to stop the cancer’s spread, and possible curative treatments.
At UCSD, scientific studies in lung cancer are particularly exciting, ranging from cancer genetics to basic biological insights. UCSD’s investigators are also exploring cancer prevention, the reduction of cancer disparities, tumor growth and metastasis, and control of symptoms.
- Medical oncologist Dr. Lyudmila Bazhenova is investigating a new antibody which has the potential to become a new treatment for small cell lung cancer.
- A UCSD team is looking at the role of circulating tumor cells in predicting behaviors of non-small cell lung cancer.
- Bin (Steve) Jiang, Ph.D., is working with UCSD radiation oncologists to develop effective image guidance techniques that can improve the precision of radiation treatment, and thus improve the treatment outcome. For example, his team is developing improved versions of image guidance techniques for respiratory gated radiotherapy, a relatively new technology of treating lung cancer, where the radiation beam in only turned on when the tumor is at the correct position, thus protecting the normal lung tissues from unnecessary irradiation.
Clinical Trials Are a Treatment Option
Clinical trials are strictly controlled human studies of new and emerging therapies or new and different ways of using known treatments.
Participation in a clinical trial gives you access to new treatments which could potentially become approved therapy down the line. By taking part in a clinical trial, you can be treated with a highly promising new drug that may not get final approval and wide distribution for some time. Also, the participation in a clinical trial widens your choice of treatment for all possible scenarios, from early stages to advanced cancer.
Through the UC San Diego Moores Cancer Center, you have access to clinical trials from the Cancer and Leukemia Group B (CALGB), the Eastern Cooperative Oncology Group (ECOG), and Southwestern Oncology Group (SWOG), as well as trials initiated by UCSD researchers and pharmaceutical companies.